AI assistant
Sending…
ClearPoint Neuro, Inc. — Director's Dealing 2026
Jan 5, 2026
32641_dirs_2026-01-05_0babb217-ccab-44f6-8440-c1d1e95ffc12.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2025-12-31
Reporting Person: BURNETT JOSEPH (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Common Stock | A | 254 | $9.57 | Acquired | 11565 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 217059 | Indirect |
Footnotes
F1: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.
F2: These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
More from ClearPoint Neuro, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19